OPHT

  0%
Previous Close
Open
Price To Book
Market Cap 0
Shares 0
Volume 0
Short Ratio
Av. Daily Volume 0

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Latest News

  1. Edited Transcript of OPHT earnings conference call or presentation 8-May-19 12:00pm GMT
  2. Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio
  3. Ophthotech Gets Rights to Gene Therapy for BEST Disease
  4. Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases
  5. 4 Gene Therapy Players Likely to Become Buyout Targets in 2019
  6. Ophthotech (OPHT) Down 2.1% Since Last Earnings Report: Can It Rebound?
  7. Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day
  8. If You Had Bought Ophthotech (NASDAQ:OPHT) Stock Three Years Ago, You’d Be Sitting On A 96% Loss, Today
  9. Top Ranked Momentum Stocks to Buy for March 7th
  10. Edited Transcript of OPHT earnings conference call or presentation 26-Feb-19 1:00pm GMT
  11. Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference
  12. Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus
  13. Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
  14. Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019
  15. Recent Analysis Shows Amerco, McKesson, Ophthotech, IQVIA, Highwoods Properties, and ABM Industries Market Influences — Renewed Outlook, Key Drivers of Growth
  16. Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
  17. Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors
  18. Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors
  19. How Many Ophthotech Corporation (NASDAQ:OPHT) Shares Do Institutions Own?